Prothena Corp. plc Stock
Price
Target price
€20.40
€20.40
-2.780%
-0.6
-2.780%
€80.10
09.05.24 / Tradegate
WKN: A1KAVV / Symbol: PRTA / Name: Prothena Corp / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Prothena Corp. plc Stock
We can see a decrease in the price for Prothena Corp. plc. Compared to yesterday it has lost -€0.600 (-2.780%).
With 13 Buy predictions and not the single Sell prediction the community is currently very high on Prothena Corp. plc.
With a target price of 80 € there is potential for a 292.16% increase which would mean more than doubling the current price of 20.4 € for Prothena Corp. plc.
Pros and Cons of Prothena Corp. plc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prothena Corp. plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prothena Corp. plc | -2.780% | -4.673% | -2.857% | -69.778% | -41.379% | 12.707% | - |
| Ardelyx Inc. | -3.860% | -10.646% | 8.836% | 81.814% | 24.879% | 28.893% | - |
| Evolus Inc | -0.840% | -4.065% | 6.306% | 28.261% | 30.387% | 71.014% | - |
| Salarius Pharmaceuticals Inc. | 4.830% | -4.405% | 6.373% | -60.901% | -21.802% | -98.210% | -99.992% |
Comments
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at HC Wainwright from $90.00 to $84.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Show more
Ratings data for PRTA provided by MarketBeat